ReviewOncoTargets and therapy2022

Amivantamab in the Treatment of Metastatic NSCLC: Patient Selection and Special Considerations.

Iacopo Petrini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.